Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis-Reference-Cited by-同舟云学术

Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis

Published:2016-05-20 Issue:7 Volume:10 Page:1118-1132
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Avtanski Dimiter B.,Nagalingam Arumugam,Tomaszewski Joseph E.,Risbood Prabhakar,Difillippantonio Michael J.,Saxena Neeraj K.,Malhotra Sanjay V.,Sharma Dipali

Funder

NIDDK NIH

NCI NIH

Avon Foundation

Breast Cancer Research Foundation (BCRF)

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference52 articles.

1. Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids;Bates;Mol. Biol. Cell,2003

2. Selective inhibition of in vitro synthesis of cancer DNA by alkaloids of beta-carboline class;Beljanski;Exp. Cell Biol,1982

3. Three alkaloids as selective destroyers of cancer cells in mice. Synergy with classic anticancer drugs;Beljanski;Oncology,1986

4. p53-mediated activation of miRNA34 candidate tumor-suppressor genes;Bommer;Curr. Biol,2007

5. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation;Brooks;Curr. Opin. Cell Biol,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA signatures underlie chemoresistance in the gemcitabine-resistant pancreatic ductal adenocarcinoma cell line MIA PaCa-2 GR;Frontiers in Genetics;2024-06-11

2. Alkaloids from Corydalis saxicola and their antiproliferative activity against cancer cells;Fitoterapia;2024-03

3. Undescribed isoquinolines from Zanthoxylum nitidum and their antiproliferative effects against human cancer cell lines;Phytochemistry;2023-01

4. Role of p53 in breast cancer progression: An insight into p53 targeted therapy;Theranostics;2023

5. Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2022-07-22